Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Somatix acquires exclusive license to gene transfer technology

July 26, 1996

Guilford obtains rights to chemotherapy drug delivery system

July 26, 1996

Ribozyme/Alza research collaboration

July 26, 1996

Techniclone International issued European patent for its Modified Antibodies Technology

July 26, 1996

Isis and ProtoGene renew drug discovery collaboration

July 26, 1996

Millennium and Wyeth-Ayerst collaborate on CNS drugs and gene therapies

July 26, 1996

Biogen and Ontogeny sign CNS drug development collaboration

July 26, 1996

Ontogen and Kanebo enter drug development collaboration

July 26, 1996

University of Michigan issued U.S. patent for gene transfer technology

July 19, 1996

CytoTherapeutics announces new biotech company

July 19, 1996

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 24, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...